Form 4: Marimed Inc. COO Timothy Shaw Reports Stock Transactions

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the acquisition and disposal of common stock and Restricted Stock Units (RSUs) on April 2, 2025.

Summary

• On April 2, 2025, Timothy Shaw, the Chief Operating Officer of Marimed Inc., reported transactions involving the company's common stock and Restricted Stock Units (RSUs).
• Shaw acquired 19,969 shares of common stock through the vesting of RSUs.
• He also disposed of 6,920 shares of common stock to satisfy tax withholding obligations.
• Following these transactions, Shaw directly owns 8,803,313 shares of common stock.
• Additionally, 2,000,000 shares are indirectly owned through the Shaw Family Trust, for which Shaw disclaims beneficial ownership.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports routine stock transactions related to executive compensation. There are no overtly positive or negative implications.

Positives

• The vesting of RSUs indicates a form of compensation and alignment of interests between the executive and the company's performance.

Negatives

• The disposal of shares to cover tax obligations, while routine, slightly reduces the executive's direct holdings.

Risks

• There are no specific risks highlighted in this document, which is a standard SEC Form 4 filing.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. They are a standard part of corporate governance and help investors understand the buying and selling activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
• Similar filings are made by executives at companies like Curaleaf, Trulieve, and Green Thumb Industries, providing investors with insights into their stock transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares due to RSU vesting.

Key Dates

Keywords

Marimed Inc., Timothy Shaw, MRMD, Form 4, SEC Filing, Stock Transaction, Restricted Stock Units, RSU, Beneficial Ownership, Chief Operating Officer